Construction and preliminary application of Symptom Cluster Scale for inflammatory bowel disease

doi:10.3761/j.issn.0254-1769.2020.12.011

Abstract

Abstract:

Objective We developed a scientific and standardized symptom clusters assessment scale for patients with inflammatory bowel disease and performed a reliability and validity test. Methods Guided by the Symptoms Experience Model,our research group developed the first draft of the scale through literature review and Delphi expert consultation. After descriptive defining of the items,we conducted pilot experiment with a small sample size and refined the scale based on patient feedback. 150 patients with inflammatory bowel disease admitted to the Department of Gastroenterology in 4 tertiary hospitals in Jiangsu Province from June to September 2019 were conveniently selected and investigated. The data was analyzed by SPSS 20.0 to determine the reliability and validity of the scale. Results The final Symptom Cluster Scale for Inflammatory Bowel Disease consisted of 18 items. The content validity index of the scale was 0.850,and the content validity index of each item was 0.941~1.000. Exploratory factor analysis extracted 5 common factors,and the cumulative variance contribution rate was 77.390%. There was a positive correlation between each factor and the total scale,the correlation coefficient was 0.580~0.857;the correlation coefficient between the total scale and the Inflammatory Bowel Disease Questionnaire was 0.925. The Cronbach’s alpha coefficient of the total scale was 0.900,and the test-retest reliability was 0.856. Conclusion The Symptom Cluster Scale for Inflammatory Bowel Disease has good reliability and validity,which can guide medical staff to comprehensively and accurately evaluate patients and provide evidence to develop individualized symptom management measures for patients with inflammatory bowel disease.

Key words: Inflammatory Bowel Disease, Symptom Clusters, Scale Construction, Reliability, Validity, Symptoms Experience Model, Nursing Care

摘要：

目的编制科学、规范的炎症性肠病患者症状群评估量表,并进行信效度检验。方法以症状经历模型为指导,通过文献回顾、德尔菲专家函询形成量表初稿;对条目进行描述性定义后进行小样本预调查,根据患者反馈完善量表。便利选取2019年6月—9月在江苏省4所三级甲等综合医院消化科门诊就诊或住院的150例炎症性肠病患者进行问卷调查。运用SPSS 20.0对数据进行项目分析,测定量表的信效度。结果最终形成的炎症性肠病患者症状群评估量表包括18个条目,量表的内容效度指数为0.850,各条目的内容效度指数为0.941~1.000。探索性因子分析提取出5个公因子,累计方差贡献率为77.390%。各因子与总量表间呈正相关,相关系数为0.580~0.857,总量表与炎症性肠病生活质量问卷的相关系数为0.925。总量表的Cronbach’s α系数为0.900,重测信度为0.856。结论炎症性肠病患者症状群评估量表具有良好的信效度,可引导医护人员精准、针对性地评估患者,为患者制订个性化的症状管理措施提供依据。

关键词: 炎症性肠病, 症状群, 量表编制, 信度, 效度, 症状经历模型, 护理

GU Fangchen,LIN Zheng,SHANG Xingchen,BIAN Qiugui,LIN Lin,ZHANG Hongjie. Construction and preliminary application of Symptom Cluster Scale for inflammatory bowel disease[J]. Chinese Journal of Nursing, 2020, 55(12): 1819-1824.

顾芳臣,林征,尚星辰,卞秋桂,林琳,张红杰. 炎症性肠病患者症状群评估量表的编制及信效度检验[J]. 中华护理杂志, 2020, 55(12): 1819-1824.

Figures/Tables 5

Table 1 Item analysis results of the Symptom Cluster Scale for Inflammatory Bowel Disease（n=148）

Table 2 The characteristic roots of each factor and the explained variation percentage of the Symptom Cluster Scale for Inflammatory Bowel Disease

Table 3 Exploratory factor analysis results of the Sy mptom Cluster Scale forI nflammatory Bowel Disease(n=. 148)

Table 4 Correlation coefficients between dimensions and correlation coefficients between dimensions and total table（r value）

Table 5 Correlation between the scores of Symptom Cluster Scale for Inflammatory Bowel Disease and the Scores of Inflammatory Bowel Disease Questionnaire（r value）

References 25

[1]	GBD 2017 Inflammatory Bowel Disease Collaborators. The glo-bal,regional,and national burden of inflammatory bowel disease in 195 countries and territories,1990—2017:a systematic analysis for the global burden of disease study 2017BD 2017[J]. Lancet Gastroenterol Hepatol, 2020,5(1):17-30. DOI URL PMID
[2]	Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century:a systematic review of population-based studies[J]. Lancet, 2018,390(10114):2769-2778. URL PMID
[3]	Farrell D, McCarthy G, Savage E. Self-reported symptom burden in individuals with inflammatory bowel disease[J]. J Crohns Colitis, 2016,10(3):315-322. URL PMID
[4]	赵媛媛, 顾洁, 张媛媛, 等. 炎症性肠病患者症状负担调查分析[J]. 中华现代护理杂志, 2018,24(16):1895-1899.
	Zhao YY, Gu J, Zhang YY, et al. Investigation and analysis on symptom burden in inflammatory bowel disease patients[J]. Chin J Mode Nurs, 2018,24(16):1895-1899.
[5]	Conley S, Proctor DD, Jeon S, et al. Symptom clusters in adults with inflammatory bowel disease[J]. Res Nurs Health, 2017,40(5):424-434. DOI URL PMID
[6]	罗丹, 林征, 卞秋桂, 等. 炎症性肠病患者感知病耻感现状及其对生活质量、服药依从性和心理状态的影响[J]. 中华护理杂志, 2018,53(9):1078-1083.
	Luo D, Lin Z, Bian QG, et al. Perceived stigma in patients with inflammatory bowel disease and its effect on psychology,medication compliance and quality of life[J]. Chin J Nurs, 2018,53(9):1078-1083.
[7]	Luo XP, Mao R, Chen BL, et al. Over-reaching beyond disease activity:the influence of anxiety and medical economic burden on health-related quality of life in patients with inflammatory bowel disease[J]. Patient Prefer Adherence, 2016,11:23-31. URL PMID
[8]	Farrell D, Savage E. Symptom burden in inflammatory bowel disease:rethinking conceptual and theoretical underpinnings[J]. Int J Nurs Pract, 2010,16(5):437-442. DOI URL PMID
[9]	Armstrong TS. Symptoms experience:a concept analysis[J]. Oncol Nurs Forum, 2003,30(4):601-606. DOI URL PMID
[10]	杜春燕. 基于症状经历模型对肾移植受者症状经历的研究[D]. 北京:北京中医药大学, 2018.
	Du CY. Research on the symptom experience of kidney transplant recipients based on the symptom experience model[D]. Beijing:Beijing University of Chinese Medicine, 2018.
[11]	中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见(2018年,北京)[J]. 中华消化杂志, 2018,38(5):292-311.
	Inflammatory Bowel Disease Group, Digestive Diseases Branch of Chinese Medical Association. Consensus opinions on the diagnosis and treatment of inflammatory bowel disease(2018,Beijing)[J]. Chin J Dig, 2018,38(5):292-311.
[12]	李峥, 刘宇. 护理学研究方法[M]. 2版. 北京: 人民卫生出版社, 2018.
	Li Z, Liu Y. Nursing research methods[M]. 2nd ed. Beijing: People’s Medical Publishing House, 2018.
[13]	吴明隆. 问卷统计分析实务:SPSS操作与应用[M]. 重庆: 重庆大学出版社, 2010.
	Wu ML. Questionnaire statistical analysis practice:SPSS operation and application[M]. Chongqing: Chongqing University Press, 2010.
[14]	李如源, 杨雪松, 穆尔扎·别克, 等. 炎症性肠病患者健康相关生活质量评价研究[J]. 中华消化杂志, 2012,32(1):24-28.
	Li RY, Yang XS, Mu EB, et al. The evaluation of health-related quality of life in patients with inflammatory bowel disease[J]. Chin J Dig, 2012,32(1):24-28.
[15]	史静琤, 莫显昆, 孙振球. 量表编制中内容效度指数的应用[J]. 中南大学学报(医学版), 2012,37(2):49-52.
	Shi JJ, Mo XK, Sun ZQ. Content validity index in scale development[J]. J Cent South Uni(Medical Science), 2012,37(2):49-52.
[16]	Robert F. DeVellis . 量表编制:理论与应用[M]. 3版. 席仲恩,杜珏(译). 重庆: 重庆大学出版社, 2016.
	Robert F. DeVellis . Scale development:theory and application[M]. 3rd ed. Xi ZE,Du J (translated). Chongqing: Chongqing University Press, 2016.
[17]	王潇, 段培蓓, 王阿芹, 等. 癌症症状群识别方法研究进展[J]. 中国护理管理, 2018,18(9):1274-1279.
	Wang X, Duan PB, Wang AQ, et al. Research progress on methods of identification of cancer symptom clusters[J]. Chin Nurs Manag, 2018,18(9):1274-1279.
[18]	Kim HJ, Abraham I, Malone PS. Analytical methods and issues for symptom cluster research in oncology[J]. Curr Opin Support Palliat Care, 2013,7(1):45-53.
[19]	林妙然, 姜小鹰, 胡荣. 急性白血病患者报告临床结局量表的编制及信效度检验[J]. 中华护理杂志, 2019,54(3):350-355.
	Lin MR, Jiang XY, Hu R. Development and validation of the patient-reported outcomes instrument for acute leukemia[J]. Chin J Nurs, 2019,54(3):350-355.
[20]	尚星辰, 林征, 卞秋桂, 等. 炎症性肠病病人自我管理行为量表的编制及信效度检验[J]. 护理研究, 2019,33(14):2374-2380.
	Shang XC, Lin Z, Bian QG, et al. Development and reliability and validity test of self-management behavior scale for patients with inflammatory bowel disease[J]. Chin Nurs Res, 2019,33(14):2374-2380.
[21]	罗丹, 林征, 卞秋桂, 等. 炎症性肠病患者自我管理体验质性研究的系统评价[J]. 中华护理杂志, 2018,53(1):41-47.
	Luo D, Lin Z, Bian QG, et al. Self-management experience of patients with inflammatory bowel disease:a systematic review of qualitative studies[J]. Chin J Nurs, 2018,53(1):41-47.
[22]	Sexton KA, Walker JR, Targownik LE, et al. The inflammatory bowel disease symptom inventory:a patient-report scale for research and clinical application[J]. Inflamm Bowel Dis, 2019,25(8):1277-1290.
[23]	Long MD. A novel index to measure patient-reported outcomes in clinical practice and research:the inflammatory bowel disease symptom inventory-ready for prime time?[J]. Inflamm Bowel Dis, 2019,25(8):1291-1292. DOI URL PMID
[24]	陈潇, 张玉侠, 俞静娴, 等. 肝移植受者症状群及其影响因素的研究[J]. 中华护理杂志, 2019,54(8):1130-1135.
	Chen X, Zhang YX, Yu JX, et al. Symptom clusters and influencing factors in liver transplantation recipients[J]. Chin J Nurs, 2019,54(8):1130-1135.
[25]	Pillai N, Dusheiko M, Maillard MH, et al. The evolution of health care utilisation and costs for inflammatory bowel disease over ten years[J]. J Crohn’s Colitis, 2019,13(6):744-754.